These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10505579)
1. Do phase III trials have clinical value? Fleischhacker WW; Hummer M J Clin Psychopharmacol; 1999 Oct; 19(5):391-2. PubMed ID: 10505579 [No Abstract] [Full Text] [Related]
2. Are medication-free periods necessary for phase 3 trials of new antipsychotic drugs? Volavka J Arch Gen Psychiatry; 1998 Mar; 55(3):280-1; 283. PubMed ID: 9510226 [No Abstract] [Full Text] [Related]
3. Molecule of the month. Bifeprunox mesilate. Drug News Perspect; 2005 Oct; 18(8):523. PubMed ID: 16391722 [No Abstract] [Full Text] [Related]
4. Regulatory science in Europe: the case of schizophrenia trials. Barbui C; Bighelli I Lancet; 2013 Oct; 382(9900):1234-5. PubMed ID: 23791471 [No Abstract] [Full Text] [Related]
5. Trial watch: phase II and phase III attrition rates 2011-2012. Arrowsmith J; Miller P Nat Rev Drug Discov; 2013 Aug; 12(8):569. PubMed ID: 23903212 [No Abstract] [Full Text] [Related]
7. Pharmaceutical company trials and the integrity of medical research. Tritsmans L; Briscoe P; Lemmens P; Bussche GV Lancet; 1996 Jun; 347(9015):1628; author reply 1628-9. PubMed ID: 8667898 [No Abstract] [Full Text] [Related]
8. The future of clinical research beyond phase III trials. Vogelbaum MA Clin Neurosurg; 2009; 56():37-9. PubMed ID: 20214028 [No Abstract] [Full Text] [Related]
9. Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia. Talpos JC Drug Discov Today; 2017 Jul; 22(7):1017-1026. PubMed ID: 28461223 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant antidotes start yielding Phase III promise. Jones D Nat Rev Drug Discov; 2015 Jan; 14(1):5-6. PubMed ID: 25549579 [No Abstract] [Full Text] [Related]
11. Phase III clinical trials in oncology. 20-21 January 2003, London, UK. Buyse M IDrugs; 2003 Mar; 6(3):187-90. PubMed ID: 12838977 [No Abstract] [Full Text] [Related]
12. Trial watch: pivotal oncology trials: outlook for Q2 2009. Nehring R Nat Rev Drug Discov; 2009 Apr; 8(4):266. PubMed ID: 19337264 [No Abstract] [Full Text] [Related]
13. When will Alzheimer's disease be cured? A pharmaceutical perspective. Townsend M J Alzheimers Dis; 2011; 24 Suppl 2():43-52. PubMed ID: 21368375 [TBL] [Abstract][Full Text] [Related]
14. Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy. Nat Rev Drug Discov; 2011 Jun; 10(6):404. PubMed ID: 21629281 [No Abstract] [Full Text] [Related]
15. DU-127090 Solvay/H Lundbeck. Wolf W Curr Opin Investig Drugs; 2003 Jan; 4(1):72-6. PubMed ID: 12625033 [TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials. Lockwood JT; Remington G Expert Opin Emerg Drugs; 2015 Sep; 20(3):407-21. PubMed ID: 26166007 [TBL] [Abstract][Full Text] [Related]
17. Clinical review of risperidone. Chouinard G; Arnott W Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574 [TBL] [Abstract][Full Text] [Related]
18. Molecule of the month. Paliperidone. Drug News Perspect; 2007 Jun; 20(5):333. PubMed ID: 17878961 [No Abstract] [Full Text] [Related]
19. Phase III trials of targeted anticancer therapies: redesigning the concept. Ocana A; Amir E; Vera-Badillo F; Seruga B; Tannock IF Clin Cancer Res; 2013 Sep; 19(18):4931-40. PubMed ID: 23881926 [TBL] [Abstract][Full Text] [Related]
20. Quarter-century quest for malaria vaccine shows signs of success. Opar A Nat Rev Drug Discov; 2011 Dec; 10(12):887-8. PubMed ID: 22129977 [No Abstract] [Full Text] [Related] [Next] [New Search]